Filing Details
- Accession Number:
- 0000950170-24-061615
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 16:05:30
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-17 16:05:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247681 | Bryan V Lawlis | C/O Geron Corporation 919 E. Hillsdale Blvd, Suite 250 Foster City CA 94404 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-15 | 35,000 | $1.94 | 35,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-15 | 35,000 | $3.75 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-15 | 35,000 | $0.00 | 35,000 | $1.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-05-20 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.715 to $3.790, inclusive. The reporting person undertakes to provide to Geron Corporation, any security holder of Geron Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- This transaction reflects an exercise and sale of options due to expire on May 20, 2024, and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 14, 2024.
- Option was fully vested.
Billionaire Hedge Funds
